Future Perspectives: Key Trends Shaping the Artificial

Source Domain: www.openpr.com

The market for Artificial Intelligence in Cardiology is expected to reach $15.19 billion by 2030, with a compound annual growth rate (CAGR) of 41.2%.
Key growth drivers include remote patient monitoring, AI-powered clinical decision support systems, and preventive cardiac care.
Leading companies in the industry include Microsoft, IBM, Philips, and others, with notable acquisitions like Stryker’s purchase of Care.AI to expand its digital healthcare portfolio.
Strategic collaborations, such as the partnership between Icahn School of Medicine and Chiba Institute of Technology, aim to enhance AI’s role in cardiology research and patient care, focusing on equity in AI applications.
The market is segmented by component (hardware, software, services), application (arrhythmia, stroke, CAD), and end-use (lifescience companies, healthcare payers, providers).

You may have missed